卵巢微乳头交界性浆液性肿瘤一例及文献复习

Ovarian Micropapillary Serous Borderline Tumor: A Case Report and Literatures Review

卵巢微乳头型浆液性交界性肿瘤(micropapillary serous borderline tumor,MPSC)是卵巢癌中非常罕见的一种病理类型,这种肿瘤不显示破坏性浸润生长,但可能与恶性行为有关,与无微乳头状结构的浆液性病变相比,双侧肿瘤、表面受累的频率更高,且盆腹腔浸润性种植的发生率更高,相当于非浸润性低级别浆液性癌。到目前为止对于MPSC的治疗仍没有明确的诊治规范或指南,微乳头结构对浆液性交界性卵巢肿瘤患者预后的影响目前仍存在争议。结合我院收治的1例伴有腹腔非浸润性种植的MPSC患者,主要对此疾病的治疗加以探讨,已期提高临床医师对本病治疗的进一步认识。

Micropapillary serous borderline tumor (MPSC) is a very rare type of ovarian cancers. Although it does not show the destructive invasive growth, it is associated with other malignant behaviors of ovarian cancer.Compared with the serous lesions without micropapillary structure, ovarian MPSC has the high probability of bilateral tumor and surface involvement, and the high incidence of invasive intraperitoneal implantation, which is equivalent to the non-invasive low-grade serous carcinoma. Until now, there are no clear clinical norms or guidelines for the treatment of MPSC. There is some controversy to the effect of micropapillary structure on the prognosis of those patients with serous borderline ovarian tumor. Combined with a case of ovarian MPSC with noninvasive intraperitoneal implantation from our hospital, this article mainly discusses the treatment of MPSC in order to improve the clinicians′ understanding.